ArticleFrontiers in cell and developmental biology2021

The Interdisciplinary Stem Cell Institute's Use of Food and Drug Administration-Expanded Access Guidelines to Provide Experimental Cell Therapy to Patients With Rare Serious Diseases.

Aisha Khan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.